{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Quality+of+Life+Forms&page=2", "query": { "intervention": "Quality of Life Forms", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Quality+of+Life+Forms&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-29T14:05:14.806Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04253964", "title": "Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Nonsmall Cell Lung Cancer", "Performance Status" ], "interventions": [ { "name": "Pembrolizumab", "type": "DRUG" }, { "name": "Atezolizumab", "type": "DRUG" }, { "name": "Cemiplimab-Rwlc", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Nab paclitaxel", "type": "DRUG" }, { "name": "Pemetrexed", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Quality of Life Questionnaire, lung cancer-specific (QLQ-LC13)", "type": "OTHER" }, { "name": "QLQ-C30 Global Health/Quality of Life Questionnaire", "type": "OTHER" }, { "name": "COPD Assessment Test and modified Medical Research Council Dyspnea Patient Reported Outcomes", "type": "OTHER" }, { "name": "PROMIS and FACT-G Questionnaires", "type": "OTHER" }, { "name": "Sleep Disorder Assessments (ISI, Berlin Sleep Questionnaire)", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 105, "start_date": "2020-07-01", "completion_date": "2027-09-01", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-09-29T14:05:14.806Z", "location_count": 2, "location_summary": "Charlotte, North Carolina • Winston-Salem, North Carolina", "locations": [ { "city": "Charlotte", "state": "North Carolina" }, { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04253964" }, { "nct_id": "NCT04195945", "title": "CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Myeloid Leukemia", "Myeloid Neoplasm" ], "interventions": [ { "name": "Liposome-encapsulated Daunorubicin-Cytarabine", "type": "DRUG" }, { "name": "Cladribine", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Recombinant Granulocyte Colony-Stimulating Factor", "type": "BIOLOGICAL" }, { "name": "Mitoxantrone", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "OTHER" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2020-05-27", "completion_date": "2026-05-20", "has_results": true, "last_update_posted_date": "2026-06-29", "last_synced_at": "2026-09-29T14:05:14.806Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT04195945" }, { "nct_id": "NCT02668809", "title": "Oral Hygiene Intervention Pilot Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dental Caries", "Gingivitis" ], "interventions": [ { "name": "oral health assessment", "type": "OTHER" }, { "name": "Questionnaires", "type": "OTHER" }, { "name": "Clinical Exam", "type": "OTHER" }, { "name": "Microbiological sampling", "type": "OTHER" }, { "name": "Monitoring Adherence", "type": "OTHER" }, { "name": "Varnish application", "type": "OTHER" }, { "name": "Consent", "type": "OTHER" }, { "name": "Educational Program", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Leonardo Marchini", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "21 Years to 120 Years" }, "enrollment_count": 81, "start_date": "2014-06", "completion_date": "2018-06", "has_results": false, "last_update_posted_date": "2018-08-28", "last_synced_at": "2026-09-29T14:05:14.806Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT02668809" }, { "nct_id": "NCT04418219", "title": "Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast Cancer", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Anatomic Stage IV Breast Cancer AJCC v8", "Metastatic Breast Carcinoma", "Prognostic Stage IV Breast Cancer AJCC v8", "Recurrent Breast Carcinoma", "Refractory Breast Carcinoma" ], "interventions": [ { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM", "type": "BIOLOGICAL" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Recombinant Interferon Alpha 2b-like Protein", "type": "BIOLOGICAL" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Quality of Life Assessment", "type": "OTHER" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "OTHER" ], "sponsor": "Thomas Jefferson University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 0, "start_date": "2020-12-21", "completion_date": "2024-01-01", "has_results": false, "last_update_posted_date": "2025-04-29", "last_synced_at": "2026-09-29T14:05:14.806Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04418219" }, { "nct_id": "NCT00005881", "title": "Quality of Life in Children Treated for Cancer", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Leukemia", "Lymphoma", "Unspecified Childhood Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "Quality of Life Forms", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "8 Years to 20 Years" }, "enrollment_count": 538, "start_date": "2000-04", "completion_date": "2006-09", "has_results": false, "last_update_posted_date": "2013-08-23", "last_synced_at": "2026-09-29T14:05:14.806Z", "location_count": 17, "location_summary": "Duarte, California • Oakland, California • Denver, Colorado + 14 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Wilmington", "state": "Delaware" }, { "city": "Des Moines", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT00005881" }, { "nct_id": "NCT04611659", "title": "Averting NAS Among Opioid-Using Young Women Receiving MAT Using Buprenorphine", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Opioid-use Disorder", "Contraception", "Neonatal Abstinence Syndrome" ], "interventions": [ { "name": "Motivational Interviewing and Educational Training (MIET)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Meharry Medical College", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "44 Years", "sex": "FEMALE", "summary": "18 Years to 44 Years · Female only" }, "enrollment_count": 80, "start_date": "2020-11", "completion_date": "2021-10-31", "has_results": false, "last_update_posted_date": "2020-11-02", "last_synced_at": "2026-09-29T14:05:14.806Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04611659" }, { "nct_id": "NCT00685893", "title": "Integrating Palliative and Critical Care (IPACC) Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Any Disease Causing Death in the ICU or Within 24 Hours of Discharge From the ICU" ], "interventions": [ { "name": "Education", "type": "BEHAVIORAL" }, { "name": "Local Champions", "type": "BEHAVIORAL" }, { "name": "Institution Feedback", "type": "BEHAVIORAL" }, { "name": "Academic Detailing", "type": "BEHAVIORAL" }, { "name": "Institutional Forms", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3498, "start_date": "2003-06", "completion_date": "2010-10", "has_results": false, "last_update_posted_date": "2013-06-27", "last_synced_at": "2026-09-29T14:05:14.806Z", "location_count": 15, "location_summary": "Bellevue, Washington • Bremerton, Washington • Burien, Washington + 5 more", "locations": [ { "city": "Bellevue", "state": "Washington" }, { "city": "Bremerton", "state": "Washington" }, { "city": "Burien", "state": "Washington" }, { "city": "Edmonds", "state": "Washington" }, { "city": "Kirkland", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00685893" }, { "nct_id": "NCT04283994", "title": "Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dementia", "Chronic Disease", "Neoplasm Metastasis", "Lung Neoplasms", "Pulmonary Disease, Chronic Obstructive", "Heart Failure, Congestive", "Liver Cirrhosis", "Kidney Failure, Chronic", "Lung Diseases, Interstitial", "Peripheral Vascular Disease", "Diabetes With End Organ Injury" ], "interventions": [ { "name": "Survey-based Patient/Clinician Jumpstart", "type": "BEHAVIORAL" }, { "name": "EHR-based Clinician Jumpstart", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 756, "start_date": "2021-07-26", "completion_date": "2025-01-27", "has_results": true, "last_update_posted_date": "2025-06-24", "last_synced_at": "2026-09-29T14:05:14.806Z", "location_count": 3, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" }, { "city": "Seattle", "state": "Washington" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT04283994" }, { "nct_id": "NCT03522077", "title": "RAVE: Radial Artery Vascular Complication and Resource Utilization", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Angiogram", "Percutaneous Coronary Intervention" ], "interventions": [ { "name": "RadAR EasyCLik plus ®-STF hemostatic pad", "type": "DEVICE" }, { "name": "TR BAND® Compression device plus ®-STF hemostatic pad", "type": "DEVICE" }, { "name": "SoftSeal®-STF hemostatic pad", "type": "DEVICE" }, { "name": "VascBand™ Hemostat", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2018-05-09", "completion_date": "2021-12-01", "has_results": true, "last_update_posted_date": "2024-10-03", "last_synced_at": "2026-09-29T14:05:14.806Z", "location_count": 1, "location_summary": "Milwaukee, Wisconsin", "locations": [ { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT03522077" }, { "nct_id": "NCT06918678", "title": "Feasibility and Efficacy of A Remote Tai Chi Program in Older Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Aging" ], "interventions": [ { "name": "Tai Chi intervention", "type": "DEVICE" }, { "name": "Usual care condiition", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "The University of Tennessee, Knoxville", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 35, "start_date": "2023-03-20", "completion_date": "2023-10-30", "has_results": false, "last_update_posted_date": "2025-04-09", "last_synced_at": "2026-09-29T14:05:14.806Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06918678" } ] }